Bone density loss in Crohn's disease: Role of TNF and potential for prevention by bupropion [3]

Gut

Volumn 53, Issue 7, 2004, Pages 1056-

  Kast, R E ^a   Altschuler, E L ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CORTICOSTEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANKYLOSING SPONDYLITIS; BONE DENSITY; BONE FRAGILITY; BONE MINERAL; COLON CROHN DISEASE; CORTICOSTEROID THERAPY; HUMAN; LETTER; MULTIPLE MYELOMA; OSTEOLYSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BONE DENSITY; BUPROPION; CROHN DISEASE; HUMANS; OSTEOPOROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042616342     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Lichtenstein GR. Evaluation of bone mineral density in IBD: current safty focus. Am J Gastroenterol 2003;98(suppl 12):S24-30.
2. Nanes MS. TNF-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1-15.
3. Bingham CO iii. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Suppl 2002;65:39.
4. Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumotology 2003;42(suppl 2):ii11-6.
5. Ritchlin CT, Haas-Smith SA, Li P, et al. Mechanism of TNF-alpha and RANKL mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003;11l:821-31.
6. Jurisic V, Colovic M. Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta 2 micro globulin, and clinical stage in multiple myeloma. Med Oncol 2002;19:133-9.
7. Campbell PA, Wang M, Amstutz HC, et al. Positive cytokine production in failed metal on metal total hip replacements. Acta Orthop Scand 2002;73:506-12.
8. Graves DT, Cochran DN. The contribution of IL-1 and TNF-alpha to periodontal tissue destruction. J Periodont 2003;74:391-401.
9. Allali F, Brebon M, Porcher R, et al. Increase in bone mineral density in patients with spondyloarthropathy treated with anti-TNF-alpha. Ann Rheum Dis 2003;62:347-9.
10. Geimold AM. New indications for treatment of chronic inflammation by TNF-alpha blockade. Am J Med Sci 2003;325:75-92.
11. Kast RE, Altschuler EL. Remission of Crohn's disease on bupropion. Gastroenterology 2001;121:1260-1.
12. Kane S, Altschuler EL, Kast RE. Crohn's disease remission on bupropion. Gastroenterology 2003;125:1290.
13. Kast RE, Altschuler EL. TNF in hepatitis B: potential role for bupropion. J Hepatol 2003;39:131-3.